Skip to content

Echinococcus IgG Control Serum BC107G



  • Virion/Serion Diagnostic Kit Control for research use (RUO)
  • Echinococcus IgG Control Serum
  • Applications: ELISA
  • IgG control serum
  • Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
  • 3 mL
Weight1 lbs
Dimensions9 × 5 × 2 in

Echinococcus reactive IgG

species reactivity




assay type

Indirect & quantitative

available size

3 mL

Echinococcus IgG Control Serum BC107G

Research area
Infectious Disease
Store at 2-8°C.
Associated products
Echinococcus granulosus Antigen (BA107VS)
Echinococcus IgG Control Serum (BC107G)
Echinococcus IgG ELISA Kit (ESR107G)
target relevance
Echinococcus granulosus
Structure and strains
Echinococcus granulosus, also called the hydatid worm, hyper tape-worm or dog tapeworm, is a cyclophyllid cestode that dwells in the small intestine of canids as an adult, but which has important intermediate hosts such as livestock and humans, where it causes cystic echinococcosis, also known as hydatid disease. The adult tapeworm ranges in length from 3 mm to 6 mm and has three proglottids ("segments") when intact an immature proglottid, mature proglottid and a gravid proglottid. The average number of eggs per gravid proglottid is 823. Like all cyclophyllideans, E. granulosus has four suckers on its scolex ("head"), and E. granulosus also has a rostellum with hooks. Several strains of E. granulosus have been identified, and all but two are noted to be infective in humans.
Echinococcosis is a zoonotic infection caused by the tapeworms Echinococcus granulosus and Echinococcus multilocularis. Infections with E. granulosus occur worldwide, while infections caused by E. multilocularis are restricted to the northern hemisphere. Sources of infection are final hosts, i. e. dogs for E. granulosus and primarily foxes for E. multilocularis as well as food contaminated with parasite eggs.

After oral ingestion of parasite eggs and hematogenous distribution, the E. granulosus larvae begin to vesiculate mainly in the liver (approx. 60% of the patients), but also in the lungs (20%) and in other organs (20%). The parasites form spherical, unilocular, fluid-filled cysts which can achieve diameters between 1 to 15 cm. In contrast to cystic echinococcosis, E. multilocularis larvae are found almost exclusively (98%) in the liver, but secondary lesions can spread metastatically to other organs (lungs, kidneys, CNS and others). The parasites grow infiltrative and tumorlike in the host tissue and, during weeks up to months, form a spongy alveolar system of connected cavities which are filled with small vesicles. The diffuse borders are usually not well delimited from adjacent liver tissue. Cysts of E. granulosus cause pathological damage or dysfunction mainly by the gradual process of space-occupying repression or displacement of vital host tissue, vessels, or organs. Consequently, clinical pathology varies greatly, depending on the site and size of the cyst, and comprise e. g. epigastric and thoracic pain. Continuous tissue destruction caused by E. multilocularis may manifest with liver dysfunction after an incubation time of 5 up to 15 years. The nonspecific symptoms usually include epigastric pain (36% of the patients) and obstructive jaundice (27%). In untreated patients lethality was found to be 94 to 100%. Treatment significantly decreased mortality to 10 to 14%.
Detection and diagnosis
Diagnosis of echinococcosis relies on clinical symptoms, imaging techniques (radiology, computer tomography) as well as on serological investigations.



Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.



relevant to this product
BC107G protocol


No results found


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.